Dashboard
Poor long term growth as Net Sales has grown by an annual rate of -8.35% and Operating profit at -49.08% over the last 5 years
With a fall in PBT of -24.42%, the company declared Very Negative results in Dec 25
With ROE of 4.8, it has a Very Expensive valuation with a 1 Price to Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
INR 135 Cr (Micro Cap)
20.00
42
2.27%
-0.19
6.85%
0.96
Total Returns (Price + Dividend) 
Latest dividend: 3 per share ex-dividend date: Sep-19-2025
Risk Adjusted Returns v/s 
Returns Beta
News
When is the next results date for Tyche Industries Ltd?
The next results date for Tyche Industries Ltd is scheduled for 28 May 2026....
Read More
Tyche Industries Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges
Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an expensive to a very expensive rating. This change comes amid a mixed performance relative to its peers and the broader market, raising questions about its price attractiveness and investment appeal.
Read More
Tyche Industries Ltd is Rated Strong Sell
Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
31-May-2026 | Source : BSENewspaper Publication og Audited Financial Results for the 4th Quarter and Year Ended March 31 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSEPursuant to Regulation 24A of SEBI(LODR) Regulations 2015 please find enclosed herewith the Annual Secretarial Compliance Report for the Year ended March 31 2026.
Board Meeting Outcome for Outcome Of Board Meeting Held On May 28 2026
28-May-2026 | Source : BSEAudited Financial Results for the quarter and year ended March 31 2026
Corporate Actions 
No Upcoming Board Meetings
Tyche Industries Ltd has declared 30% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Silver Oak Technologies Private Limited (19.31%)
Plutus Techlabs Private Limited (6.4%)
26.55%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 53.12% vs -25.28% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -36.81% vs 19.74% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -25.51% vs 8.98% in Sep 2024
Growth in half year ended Sep 2025 is -41.22% vs 14.87% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -30.42% vs -2.71% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -49.65% vs 13.02% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -18.08% vs -5.81% in Mar 2025
YoY Growth in year ended Mar 2026 is -44.08% vs 1.39% in Mar 2025